3.02 | QLD OPIOID TREATMENT PROGRAM - Understanding opioid dependence, assessment and treatment

By the end of this module, learners will be able to:

• describe opioid dependence as a medical diagnosis,
• describe common presentations for patients who use opioids and identify high-risk medication interactions,
• discuss patient goals and conduct a thorough substance use / history assessment,
• identify effective opioid dependence treatment options for patients, including opioid withdrawal management,
• practice safe treatment management of patients receiving opioid dependence treatment.

NB: This is the first of two modules which require successful, sequential completion in order to apply for approval as a Level 2 QOTP prescriber in Queensland, whereby you can then apply to prescribe buprenorphine-naloxone and long-acting injection buprenorphine formulations to patients.

Further completion of a third module "Buprenorphine-mono and methadone" followed by a clinical placement shadowing an existing Level 1 prescriber - is required in order to become a 'Level 1 Full QOTP Prescriber', whereby you can prescribe all opioid dependence treatment medications available in Queensland.

This module is accredited for:

• 0.5 hours of Educational Activities and 0.5 hours of Reviewing Performance with RACGP; and
• 1 hours of CPD with ACRRM. 

Please refer to your Statement of Completion for full details.

NB: Insight uploads CPD hours quarterly to ACRRM and RACGP.